Predictive Clinical Features for Response to Adjuvant Immunotherapy in Stage II,III and IV Resected Melanoma

Conditions

• Melanoma

Interventions

• OTHER: Frequency and duration of response to adjuvant immunotherapy according to clinical features
• OTHER: Frequency of each type of relapse (i. e. local, distant, unique or multiple) to adjuvant therapy according to clinical features
• OTHER: Duration of relapse-free survival according to clinical features
• OTHER: Duration of overall survival according to clinical features
• OTHER: Overall response rate
• OTHER: Frequency of adverse events according to clinical features

Sponsor

Hospices Civils de Lyon